VSTM Latest Headlines

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), Tiziana Life Sciences (TLSA) and Verastem (VSTM)

at www.tipranks.com (Mon, 2-Nov 9:41 PM)

VSTM Trades Above Its $8.00 Offering Price as Verastem Prices $250 Million Stock and Pre-Funded Warrant Deal

Market Chameleon (Thu, 15-Oct 11:34 AM)

Verastem Prices $250 Million Stock and Pre-Funded Warrant Offering at $8.00 With Proceeds Aimed at VS-7375 Development

Market Chameleon (Wed, 14-Oct 10:29 AM)

Verastem Oncology Prices $250 Million Offering at $8.00 to Fund VS-7375 and Broader Pipeline Work

Market Chameleon (Wed, 14-Oct 7:05 AM)

Verastem spotlights RAMP 201 data: triple wild-type LGSOC shows 18% ORR and 13-month mPFS

Market Chameleon (Fri, 2-Oct 9:27 AM)

Verastem Highlights Two-Year RAMP 201 Follow-Up With 31.10-Month Median Duration of Response in Recurrent LGSOC

Market Chameleon (Tue, 29-Sep 8:54 AM)